Sort
261,768 grants matching “gene therapy”
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$871,147Pietro P Sanna · Scripps Research Institute, The · R01 · FY2022 · DA
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques
$871,114Donald L Sodora · Seattle Children'S Hospital · R01 · FY2025 · AI
MULTICENTER CAREER DEVELOPMENT PROGRAM FOR PHYSICAL AND OCCUPATIONAL THERAPY
$871,074Michael J Mueller · Washington University · K12 · FY2015 · HD
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$871,023William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Targeting regulators of cellular gene transcription to impact HIV latency
$870,956Douglas D Richman · Veterans Medical Research Fdn/San Diego · P01 · FY2010 · AI
Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig
$870,946Michael David Alpert · Emmune, Inc · R44 · FY2021 · AI
Genomics and Proteomics of Head and Neck Cancer
$870,939Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2013 · DC
Signal and Transcription Factor Network interactions in Head and Neck Cancer
$870,939Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2013 · DC
NF-kappaB in pathogenesis and therapy of head and neck cancer
$870,939Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2013 · DC
Enhanced radiotherapy for pediatric glioma via synthetic lethal vulnerabilities
$870,926Dipanjan Chowdhury · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Therapeutic targets and novel anticancer agents for endocrine cancers
$870,926Electron Kebebew · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Assessment, Therapy and Prevention Of Autoimmune Disease
$870,917Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
GENERAL CLINICAL RESEARCH CENTER
$870,873Mount Sinai School Of Medicine Of Nyu · M01 · FY2001 · RR
Mechanisms of Cell-Based Heart Regeneration
$870,813Charles E Murry · University Of Washington · R01 · FY2019 · HL
Mosaic: post-zygotic mutations in vascular malformations
$870,804James T Bennett · Seattle Children'S Hospital · R01 · FY2023 · HL
Immunobiology and therapy of oral mucosal and salivary gland chronic graft-versus-host disease
$870,744Jacqueline Mays · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE
Manufacturing Development and Commercial Readiness of an Adeno-Associated Virus-Based Gene Therapy for the Treatment of Leber Congenital Amaurosis Type 1
$870,675Kevin P Mouillesseaux · Atsena Therapeutics, Inc. · R44 · FY2025 · EY
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease
$870,663Hong Chen · Boston Children'S Hospital · R01 · FY2025 · HL
Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease
$870,663Hong Chen · Boston Children'S Hospital · R01 · FY2023 · HL
Mesocale And Nanoscale Technologies Integrated by Structures for DNA Repair Complexes (MANTIS-DRC)
$870,594John A Tainer · University Of Tx Md Anderson Can Ctr · R35 · FY2023 · CA
Therapuetic effector functions of AAV-expressed transgenes
$870,577Ronald C Desrosiers · Scripps Florida · P01 · FY2016 · AI
Genetic Prediction for Treatment Resistance in Kawasaki Disease
$870,456Michael A Portman · Seattle Children'S Hospital · R01 · FY2022 · HL
Gag Trafficking, Assembly, and Release
$870,446Eric Freed · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Specialized ribosomes in control of gene expression and embryonic development
$870,398Maria Barna · University Of California, San Francisco · DP2 · FY2011 · OD
Mapping the Progression to HFpEF in the Elderly through Longitudinal Changes in Cardiac Function
$870,355Amil M Shah · Brigham And Women'S Hospital · R01 · FY2020 · HL